We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Honeywell (HON) Chosen by KIPIC for PRIZe Project in Kuwait
Read MoreHide Full Article
Honeywell International Inc. (HON - Free Report) recently announced that its business unit, Honeywell Process Solutions (“HPS”), has been chosen by Kuwait Integrated Petroleum Industries Company (“KIPIC”) as the main automation contractor in Kuwait. KIPIC will be using HPS’s front-end engineering design and advanced process control technology for its Petrochemicals and Refinery Integration Al Zour Project (PRIZe) to reach production targets quickly and more effectively.
The project will help to considerably increase the domestic manufacturing capabilities of petrochemicals, aromatics and gasoline in Kuwait. As a matter of fact, when completed, the PRIZe project will be Kuwait’s first integrated refining and petrochemicals complex that will enable KIPIC to cater to the increasing requirements of fuels and petrochemical products in the country.
In addition, the company’s business unit, Honeywell UOP, received a deal from KIPIC to update the Al Zour complex. Notably, Honeywell UOP will be responsible for revising the configuration and capacity of the complex’s gasoline production facilities, key equipment, and catalysts and adsorbents, among others.
Our Take
Honeywell is experiencing strength in its long-cycle businesses in U.S. defense, warehouse automation, process solutions and building technologies, as well as robust demand for aftermarket service business. Strength in the company’s process solutions business driven by solid automation portfolio coupled with strong demand for equipment is likely to keep boosting revenues of its Performance Materials and Technology segment.
However, weakness in the Safety and Productivity Solutions segment on account of lower volumes of sales due to softness in its productivity products business, distributor destocking and fewer large project rollouts remains a concern.
Year to date, the Zacks Rank #3 (Hold) company’s shares have gained 37.7% compared with the industry’s rally of 26.8%.
Carlisle surpassed estimates in each of the preceding four quarters, the average positive earnings surprise being 18.58%.
ITT outpaced estimates in each of the preceding four quarters, the average positive earnings surprise being 7.85%.
Macquarie outpaced estimates twice in the preceding four quarters, the average positive earnings surprise being 5.34%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Honeywell (HON) Chosen by KIPIC for PRIZe Project in Kuwait
Honeywell International Inc. (HON - Free Report) recently announced that its business unit, Honeywell Process Solutions (“HPS”), has been chosen by Kuwait Integrated Petroleum Industries Company (“KIPIC”) as the main automation contractor in Kuwait. KIPIC will be using HPS’s front-end engineering design and advanced process control technology for its Petrochemicals and Refinery Integration Al Zour Project (PRIZe) to reach production targets quickly and more effectively.
The project will help to considerably increase the domestic manufacturing capabilities of petrochemicals, aromatics and gasoline in Kuwait. As a matter of fact, when completed, the PRIZe project will be Kuwait’s first integrated refining and petrochemicals complex that will enable KIPIC to cater to the increasing requirements of fuels and petrochemical products in the country.
In addition, the company’s business unit, Honeywell UOP, received a deal from KIPIC to update the Al Zour complex. Notably, Honeywell UOP will be responsible for revising the configuration and capacity of the complex’s gasoline production facilities, key equipment, and catalysts and adsorbents, among others.
Our Take
Honeywell is experiencing strength in its long-cycle businesses in U.S. defense, warehouse automation, process solutions and building technologies, as well as robust demand for aftermarket service business. Strength in the company’s process solutions business driven by solid automation portfolio coupled with strong demand for equipment is likely to keep boosting revenues of its Performance Materials and Technology segment.
However, weakness in the Safety and Productivity Solutions segment on account of lower volumes of sales due to softness in its productivity products business, distributor destocking and fewer large project rollouts remains a concern.
Year to date, the Zacks Rank #3 (Hold) company’s shares have gained 37.7% compared with the industry’s rally of 26.8%.
Key Picks
Some better-ranked stocks from the same space are Carlisle Companies Incorporated (CSL - Free Report) , ITT Inc. (ITT - Free Report) and Macquarie Infrastructure Company . All these companies carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Carlisle surpassed estimates in each of the preceding four quarters, the average positive earnings surprise being 18.58%.
ITT outpaced estimates in each of the preceding four quarters, the average positive earnings surprise being 7.85%.
Macquarie outpaced estimates twice in the preceding four quarters, the average positive earnings surprise being 5.34%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>